Intellia Therapeutics Inc. News
Alnylam's 5th Drug Launches in July, Disrupting Commercial Landscape
A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.
Cramer's Mad Money Recap 2/1: Colgate-Palmolive, Stanley Black & Decker
Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.
Cathie Wood as Counter Indicator? Crispr Stumbles
Cathie Wood's Ark Investment bought shares of Germany’s Crispr Tuesday, a media report says. The stock slid on Wednesday.
Intellia Stock Jumps on Progress With Gene-Editing Treatment
'These data open a new era of medicine – one that holds the potential of curing genetic disease,' Intellia said. Its shares are higher.
Intellia Therapeutics Leads Gene-Editing Stock Rally
Intellia Therapeutics rises and other gene-editing stocks follow suit.
Elon Musk Says Only Two Things Could Make Him Leave Tesla
Tesla CEO Musk discusses succession plans and Twitter with shareholders.
Caesars Inches Closer to Huge Las Vegas Strip Move
The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.
Elon Musk Has Bad News About Tesla's Cybertruck
Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023